scholarly article | Q13442814 |
P50 | author | Laurent Poirel | Q57551509 |
Patrice Nordmann | Q63214194 | ||
Johann D D Pitout | Q87674893 | ||
P2093 | author name string | Gisele Peirano | |
Akke K van der Bij | |||
Veronika L Tchesnokova | |||
Michael Costello | |||
Joshua L Freeman | |||
P2860 | cites work | Establishment of a universal size standard strain for use with the PulseNet standardized pulsed-field gel electrophoresis protocols: converting the national databases to the new size standard | Q24522329 |
Extended-spectrum beta-lactamases: a clinical update | Q24534999 | ||
Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing | Q29614699 | ||
The CTX-M beta-lactamase pandemic. | Q30356558 | ||
Rapid and simple determination of the Escherichia coli phylogenetic group | Q33919655 | ||
Population structure, virulence potential and antibiotic susceptibility of uropathogenic Escherichia coli from Northwest England. | Q34057927 | ||
qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States | Q34973794 | ||
Clinical and molecular characteristics of extended-spectrum-beta-lactamase-producing Escherichia coli causing bacteremia in the Rotterdam Area, Netherlands | Q35065929 | ||
Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme | Q35127937 | ||
Molecular epidemiology over an 11-year period (2000 to 2010) of extended-spectrum β-lactamase-producing Escherichia coli causing bacteremia in a centralized Canadian region | Q35689028 | ||
Molecular epidemiology of CTX-M-producing Escherichia coli in the Calgary Health Region: emergence of CTX-M-15-producing isolates | Q35758933 | ||
Characterization of globally spread Escherichia coli ST131 isolates (1991 to 2010) | Q36086484 | ||
Plasmid-mediated qepA gene among Escherichia coli clinical isolates from Japan | Q36538723 | ||
Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli | Q36607290 | ||
Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern | Q37091253 | ||
Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans | Q37220795 | ||
Molecular characteristics of extended-spectrum-beta-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: emergence of clone ST131 as a cause of community-acquired infections | Q37247785 | ||
Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004 | Q37247793 | ||
Four main virotypes among extended-spectrum-β-lactamase-producing isolates of Escherichia coli O25b:H4-B2-ST131: bacterial, epidemiological, and clinical characteristics. | Q37264353 | ||
The epidemic of extended-spectrum-β-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx | Q37408471 | ||
Virulence patterns in a murine sepsis model of ST131 Escherichia coli clinical isolates belonging to serotypes O25b:H4 and O16:H5 are associated to specific virotypes | Q37534226 | ||
Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4. | Q37671098 | ||
Rapid and specific detection, molecular epidemiology, and experimental virulence of the O16 subgroup within Escherichia coli sequence type 131. | Q37713679 | ||
Comparison of Escherichia coli ST131 pulsotypes, by epidemiologic traits, 1967-2009. | Q40028752 | ||
Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15. | Q42111230 | ||
High prevalence of ST131 isolates producing CTX-M-15 and CTX-M-14 among extended-spectrum-beta-lactamase-producing Escherichia coli isolates from Canada | Q42111425 | ||
Molecular epidemiology of Escherichia coli sequence type 131 and Its H30 and H30-Rx subclones among extended-spectrum-β-lactamase-positive and -negative E. coli clinical isolates from the Chicago Region, 2007 to 2010. | Q42872176 | ||
Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals | Q43111830 | ||
The presence of genes encoding for different virulence factors in clonally related Escherichia coli that produce CTX-Ms. | Q43955125 | ||
Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. | Q46852401 | ||
Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains | Q47714144 | ||
Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli from Rio de Janeiro, Brazil. | Q54358049 | ||
Characteristics of infections caused by extended-spectrum β-lactamase-producing Escherichia coli from community hospitals in South Africa. | Q54365603 | ||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Escherichia coli | Q25419 |
P304 | page(s) | 3762-3767 | |
P577 | publication date | 2014-04-21 | |
P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
P1476 | title | Characteristics of Escherichia coli sequence type 131 isolates that produce extended-spectrum β-lactamases: global distribution of the H30-Rx sublineage | |
P478 | volume | 58 |
Q36887866 | Activity of Ceftazidime-Avibactam against Extended-Spectrum- and AmpC β-Lactamase-Producing Enterobacteriaceae Collected in the INFORM Global Surveillance Study from 2012 to 2014. |
Q28067176 | Antimicrobial resistance in Enterobacteriaceae in Brazil: focus on β-lactams and polymyxins |
Q35607916 | Bactericidal monoclonal antibodies specific to the lipopolysaccharide O antigen from multidrug-resistant Escherichia coli clone ST131-O25b:H4 elicit protection in mice. |
Q41480033 | CTX-M-27- and CTX-M-14-producing, ciprofloxacin-resistant Escherichia coli of the H30 subclonal group within ST131 drive a Japanese regional ESBL epidemic |
Q30395087 | Comparative Genome Analysis of Extended-Spectrum-β-Lactamase-Producing Escherichia coli Sequence Type 131 Strains from Nepal and Japan |
Q53704735 | Comprehensive Molecular Characterization of Escherichia coli Isolates from Urine Samples of Hospitalized Patients in Rio de Janeiro, Brazil. |
Q40190138 | Epidemic Emergence in the United States of Escherichia coli Sequence Type 131-H30 (ST131-H30), 2000 to 2009. |
Q26749590 | Escherichia coli β-Lactamases: What Really Matters |
Q57930070 | Extended-spectrum β-lactamase-producing and carbapenemase-producing Enterobacteriaceae |
Q90645279 | Extensive Genetic Commonality among Wildlife, Wastewater, Community, and Nosocomial Isolates of Escherichia coli Sequence Type 131 (H30R1 and H30Rx Subclones) That Carry blaCTX-M-27 or blaCTX-M-15 |
Q26752573 | Fluoroquinolone-Resistant Enteric Bacteria in Sub-Saharan Africa: Clones, Implications and Research Needs |
Q37023267 | Genetic Features of MCR-1-Producing Colistin-Resistant Escherichia coli Isolates in South Africa |
Q56952615 | Genetic relatedness of Staphylococcus aureus isolates obtained from cystic fibrosis patients at a tertiary academic hospital in Pretoria, South Africa |
Q40171775 | Genomic Analysis of Multidrug-Resistant Escherichia coli from North Carolina Community Hospitals: Ongoing Circulation of CTX-M-Producing ST131-H30Rx and ST131-H30R1 Strains |
Q28112087 | Global Escherichia coli Sequence Type 131 Clade with blaCTX-M-27 Gene |
Q90218796 | Global Evolution of Pathogenic Bacteria With Extensive Use of Fluoroquinolone Agents |
Q91713655 | High Prevalence of ST131 Subclades C2-H30Rx and C1-M27 Among Extended-Spectrum β-Lactamase-Producing Escherichia coli Causing Human Extraintestinal Infections in Patients From Two Hospitals of Spain and France During 2015 |
Q35843094 | High prevalence of oxacillinases in clinical multidrug-resistant Acinetobacter baumannii isolates from the Tshwane region, South Africa - an update. |
Q40239533 | High-Resolution Melting Analysis for Rapid Detection of Sequence Type 131 Escherichia coli |
Q41220729 | Intensity and Mechanisms of Fluoroquinolone Resistance within the H30 and H30Rx Subclones of Escherichia coli Sequence Type 131 Compared with Other Fluoroquinolone-Resistant E. coli |
Q37120155 | Isolation and Characterization of Escherichia coli Sequence Type 131 and Other Antimicrobial-Resistant Gram-Negative Bacilli from Clinical Stool Samples from Veterans |
Q38922047 | Longitudinal genomic surveillance of multidrug-resistant Escherichia coli carriage in a long-term care facility in the United Kingdom |
Q53699618 | Molecular Epidemiology of Staphylococcus epidermidis Implicated in Catheter-Related Bloodstream Infections at an Academic Hospital in Pretoria, South Africa. |
Q35647555 | Molecular characteristics of extended-spectrum cephalosporin-resistant Enterobacteriaceae from humans in the community |
Q40959363 | Molecular characterization of bacteremic Escherichia coli isolates in Romania |
Q30240591 | Plasmid-mediated quinolone resistance in Enterobacteriaceae: a systematic review with a focus on Mediterranean countries. |
Q30397339 | Population structure of Japanese extraintestinal pathogenic Escherichia coli and its relationship with antimicrobial resistance |
Q47123962 | Prevalence and characteristics of ST131 clone among unselected clinical Escherichia coli in a Chinese university hospital |
Q37334691 | Prevalence and risk factors for extended-spectrum β-lactamase-producing Escherichia coli causing community-onset urinary tract infections in Colombia |
Q92404356 | Sequence Types, Clonotypes, Serotypes, and Virotypes of Extended-Spectrum β-Lactamase-Producing Escherichia coli Causing Bacteraemia in a Spanish Hospital Over a 12-Year Period (2000 to 2011) |
Q58694590 | Systematic review in South Africa reveals antibiotic resistance genes shared between clinical and environmental settings |
Q30393531 | Tackling Drug Resistant Infection Outbreaks of Global Pandemic Escherichia coli ST131 Using Evolutionary and Epidemiological Genomics |
Q30386217 | The Pandemic H30 Subclone of Escherichia coli Sequence Type 131 Is Associated With Persistent Infections and Adverse Outcomes Independent From Its Multidrug Resistance and Associations With Compromised Hosts. |
Q33806382 | The Pandemic H30 Subclone of Sequence Type 131 (ST131) as the Leading Cause of Multidrug-Resistant Escherichia coli Infections in the United States (2011-2012). |
Q30300020 | The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae |
Q90050491 | Understanding the Epidemiology of Multi-Drug Resistant Gram-Negative Bacilli in the Middle East Using a One Health Approach |
Q47104393 | Virulence genes and subclone status as markers of experimental virulence in a murine sepsis model among Escherichia coli sequence type 131 clinical isolates from Spain. |